Skip to search formSkip to main contentSkip to account menu

OSI-461

Known as: OSI 461, OSI461 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
The novel compound OSI-461 induces apoptosis and growth arrest in human acute myeloid leukemia cells
Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy. Treatment of patients suffering from high-risk AML as… 
2005
2005
Activation of Protein Kinase G Upregulates Expression of 15-Lipoxygenase-1 in Human Colon Cancer Cells
Recent studies indicate that the induction of apoptosis in human colon cancer cells by certain nonsteroidal antiinflammatory… 
Review
2004
Review
2004
OSI-461 (OSI).
OSI Pharmaceuticals is developing OSI-461, a potent analog of exisulind, for the potential treatment of cancer and inflammatory… 
2004
2004
Results of a pilot trial of OSI-461 in patients with chronic lymphocytic leukemia
6676 Background: OSI-461 is a selective apoptotic antineoplastic drug (SAAND), a novel class of drugs that induce apoptosis by… 
2004
2004
Results of a pilot trial of OSI-461 in patients with chronic lymphocytic leukemia.
6676 Background: OSI-461 is a selective apoptotic antineoplastic drug (SAAND), a novel class of drugs that induce apoptosis by… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)